drugset / Trial / NCT02366676

Efficacy of IARULIL® in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract

NCT02366676

Phase 4 Completed 105 enrolled Samsung Medical Center
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the efficacy of Combined Intravesical Therapy With Hyaluronic Acid and Chondroitin Sulphate in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract

Timeline

Start
2014-01
Primary completion
2018-01
Completion
2019-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Hyaluronic Acid Other / unclassified Other

Indications